Vaccines are considered one of the most important medical intervention strategies ever implemented. Conjugate vaccines, a specific type of vaccine, have been employed to eliminate bacterial infections for decades and are considered some of the most efficacious vaccines as they are able to elicit immunological memory in all age groups, including, children two years of age and younger. Traditionally conjugate vaccine production has been performed using multiple rounds of purification and chemical cross-linking to covalently conjugate a bacterial polysaccharide to a protein carrier. This process is notoriously slow, complex, and not conducive for all bacterial polysaccharides. To bypass this labor intensive chemical process, VaxNewMo exploits the protein glycosylation systems of bacteria to generate "bioconjugate" vaccines using the laboratory safe Escherichia coli. Currently, VaxNewMo is developing next generation glycoengineered bioconjugate vaccines against pneumococcal pneumonia using its patented conjugating enzyme technology. VaxNewMo has the only conjugating enzyme technology capable of directly transferring pneumococcal capsular polysaccharides to a carrier protein strategically placing our company for optimal growth within the conjugate vaccine space. Our glycoengineering strategy streamlines the production of conjugate vaccines enabling VaxNewMo to produce a more comprehensive pneumococcal conjugate vaccine with more serotype coverage. Importantly, our conjugating enzyme technology is not limited to only pneumococcal polysaccharides, opening the door for novel bioconjugate vaccines against some of the world's most dangerous bacterial pathogens.
Company Details
- Founded
- -
- Address
- 4320 Forest Park Ave,
- in****@****wmo.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vaxnewmo.com
- Keywords
- Vaccine, Conjugate Vaccine, Glycoengineering, Bioconjugation, Pneumococcal conjugate vaccine.
- HQ
- St. Louis, Missouri
Vaxnewmo, Llc Questions
Vaxnewmo, Llc's website is vaxnewmo.com
Vaxnewmo, Llc's LinkedIn profile is https://www.linkedin.com/company/vaxnewmo
Vaxnewmo, Llc's industry is
Biotechnology Research
Vaxnewmo, Llc's top competitors are
Bacterial Fermentation Pty Ltd.,
Mauri Fermentation China Pty Limited,
Omniose,
Science Made Beerable,
Vinoscan,
Kimberly Coffey Foundation,
Biologics Mdpi,
The Elder Tree,
3gen Vaccines, Inc.,
Re-Gen Active Lab.
Vaxnewmo, Llc's support email address is info@vaxnewmo.com
Vaxnewmo, Llc's categories are Biotechnology Research
Vaxnewmo, Llc's founding year is 2016
